Skip to main content

Table 1 Clinical and endoscopic data of the studied groups

From: Endoscopic injection sclerotherapy versus N-Butyl-2 Cyanoacrylate injection in the management of actively bleeding esophageal varices: a randomized controlled trial

Variables Sclerotherapy group N: 56 (%) Cyanoacrylate group N: 57 (%) P- value
Age (years)    0.101
 Range (30–82) (28–75)  
 Mean ± SD 58.43 ± 9.93 55.26 ± 10.38  
Sex    0.438
 Male 42 (75%) 39 (68.42%)  
 Female 14 (25%) 18 (31.58%)  
Previous bleeding attacks 28 (50%) 31 (54.39%) 0.641
Child Pugh class    0.878
 A 13 (23.21%) 15 (26.32%)  
 B 23 (41.07%) 24 (42.11%)  
 C 20 (35.71%) 18 (31.68%)  
Hemodynamic instability 47 (83.93%) 42 (73.68%) 0.183
Grade of esophageal varices    0.640
 F1 2 (3.57%) 4 (7.02%)  
 F2 22 (39.29%) 24 (42.11%)  
 F3 32 (57.14%) 29 (50.88%)